CMS vs CYTK · P/E 20, $22.42B cap vs rev $18.5M
CMS Energy Corporation (CMS) versus Cytokinetics Inc (CYTK) — a side-by-side from cached financials, not a winner call.
CMS Energy Corporation (CMS) is a utilities - regulated electric company listed on US.
Cytokinetics Inc (CYTK) is a biotechnology company listed on US.
CMS does not have a complete income-statement cache yet.
Latest reported CYTK revenue for 2024-12-31 was $18.5M. Net income was -$589.5M. Revenue was up 145.3% from 2023-12-31 to 2024-12-31. CYTK currently screens at market cap $4.05B.
CMS currently screens at market cap $22.42B and trailing P/E 20.1. CYTK currently screens at market cap $4.05B.
Not investment advice. Open the CMS and CYTK stock pages for the full models.
Not investment advice.